In this regard, the increase of intracellular cAMP is reported to be pro-apoptotic in leukemic cells and anti-apoptotic in normal hematopoietic cells as CRL-1991, being the reason why some cancer treatments use cAMP analogs, phosphodiesterase E inhibitors, and adenyl cyclase activators [31]. The gene discussed is ADCY1; the disease is cancer.